Table 2. Quantitative analysis of prospective studies investigating the association between spirometry prior to upper abdominal surgery and postoperative pulmonary complications*1.
Study | Index test | Reference standard | |||||||
First author,year (reference) | Number of patients | Standards for spirometry | Prevalence of PPC (%) | Index parameter cut-off value | Sensitivity | Specificity | PPV | NPV | For/against spirometry*2 |
Kocabas 1996 (e17) | 60 | ATS | 35% | FEV1 < 1,25 l | 50% | 70% | 38% | 70% | against*4 |
FEV1 % < 50% | 62% | 70% | 38% | 70% | |||||
FEV1/FVC < 50% | 38% | 65% | 14% | 65% | |||||
Abnormal spirometry*3 | 67% | 76% | 67% | 76% | |||||
Barisione 1997 (e19) | 361 | ATS, ERS | 14% | Abnormal spirometry*3 | 84% | 99% | 95% | 98% | for |
Kanat 2007 (e27) | 60 | ATS, ERS | 58% | Abnormal spirometry*3 | 66% | 55% | 71% | 55% | for |
Jeong 2013 (e33) | 538 | GOLD | 2% | Abnormal spirometry*3 | 6% | 99% | 60% | 99% | for*5 |
= Univariate analysis, = multivariate analysis; study design: findings/conclusions based on: univariate analysis, multivariate analysis.
*1 Only studies with a low risk of selection bias in QUADAS-2 analysis were included.
*2 Conclusions drawn by the authors based on published study findings and clinical considerations
*3 According to the definition given in the study concerned
*4 Clinical parameters appeared to be non-inferior to spirometry.
*5 Multivariable analysis was performed only for the outcome measure “postoperative morbidity” (this includes surgical complications such as anastomosis leakage and wound complications)
ATS, American Thoracic Society; ERS, European Respiratory Society; FEV 1, forced expiratory volume in one second; FVC, forced vital capacity; GOLD, Global Initiative for Chronic Obstructive Lung Disease; NPV, negative predictive value; PFT, pulmonary function tests; PPC, postoperative pulmonary complications; PPV, positive predictive value; QUADAS, Quality Assessment of Diagnostic Accuracy Studies